Urotensin‐II receptor peptide agonists

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Medicinal research reviews (Print)

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/med.20001PMID 15224381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cited by this paper
• Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

  2002cited by this paper
• Structural studies on Hgr3 orphan receptor ligand prolactin-releasing peptide.

  2002cited by this paper
• Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.

  2002cited by this paper
• Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.

  2002influential reference
• Is urotensin‐II the new endothelin?

  2002cited by this paper
• Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system.

  2002cited by this paper
• Structural requirements at the N-terminus of urotensin II octapeptides.

  2002cited by this paper
• A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.

  2002cited by this paper
• Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.

  2002cited by this paper
• A new ligand for the urotensin II receptor

  2002cited by this paper
• Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).

  2002cited by this paper
• Depressor and regionally‐selective vasodilator effects of human and rat urotensin II in conscious rats

  2001cited by this paper
• Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

  2000cited by this paper
• Urotensin II: fish neuropeptide catches orphan receptor.

  2000cited by this paper
• Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.

  1999cited by this paper
• Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• "Teflon-coated peptides": hexafluoroacetone trihydrate as a structure stabilizer for peptides.

  1997cited by this paper
• NMR and dynamical simulated annealing studies on the solution conformation of urotensin II.

  1994cited by this paper
• New evidence for a membrane-bound pathway in hormone receptor binding.

  1993cited by this paper
• Viscosity as a conformational sieve. NOE of linear peptides in cryoprotective mixtures

  1991cited by this paper
• Contraction of major artery segments of rat by fish neuropeptide urotensin II.

  1987cited by this paper
• Contraction of rat thoracic aorta strips induced by phorbol 12-myristate 13-acetate.

  1987cited by this paper
• Characterization of the biologically and antigenically important regions of urotensin II.

  1986cited by this paper
• Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes.

  1985cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper

• Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor

  2022cites this paper
• Homology Modelling of Urotension-2 Receptor (UTS2R): Potential Target for Human Pharmacotherapy

  2016cites this paper
• Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.

  2016cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• Urantide Conformation and Interaction with the Urotensin‐II Receptor

  2014cites this paper
• New insight into the binding mode of peptides at urotensin‐II receptor by Trp‐constrained analogues of P5U and urantide

  2013cites this paper
• Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells

  2011cites this paper
• Optimization of isochromanone based urotensin II receptor agonists.

  2010cites this paper
• A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects

  2010cites this paper
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Spare interactions of highly potent [Arg(14),Lys(15)]nociceptin for cooperative induction of ORL1 receptor activation.

  2009cites this paper
• Possible Pathogenic Link Between Migraine and Urotensin-II

  2008cites this paper
• Novel Markers of Hemodynamic Stress

  2006cites this paper
• Urotensin-II and UII-receptor expression and function in the rat adrenal cortex.

  2006cites this paper
• Urotensin-II receptor antagonists.

  2006cites this paper
• Endogenous Vasoactive Peptides

  2003cites this paper